Rationale: Lung fibroblasts are a major source of several cytokines including CC chemokine eotaxin. We aimed to study the regulation of eotaxin-1/CCL11 production by dexamethasone and analyze its molecular mechanisms in human lung fibroblasts.
Introduction
Asthma is a chronic inflammatory disorder of the airways in which many cells, especially eosinophils, may play important roles through the release of various mediators (1, 2) . Chronic inflammation may be associated with bronchial hyperresponsiveness, variable airflow limitation and respiratory symptoms. A prominent pathophysiological feature of asthma is airway remodeling, along with airway inflammation. A link between airway inflammation and airway remodeling in asthma has recently been proposed (1) (2) (3) .
In the airways of asthmatic subjects, there is usually extensive infiltration of the airway lumen and wall with eosinophils and lymphocytes accompanied by vasodilatation, microvascular leakage, and epithelial disruption (1, 2) . Eosinophil recruitment at the airway tissue is a complex mechanism. Chemokines involved in the migration and activation of blood eosinophils such as eotaxin may be produced by several types of cells, including airway fibroblasts that have the potential to synthesize and release a variety of proinflammatory and profibrotic cytokines (4) (5) (6) (7) .
Eotaxin/CCL11, a CC chemokine with potent direct chemoattractant effects on eosinophils, is known to be regulated by Th2 cytokines, such as IL-4 and IL-13 (6, 8, 9) .
Eotaxin also regulates migration of mast cell progenitors into inflamed tissue and mast cell activation, and is likely to play an indirect role in airway remodeling through recruitment of eosinophils and mast cells, which have profibrogenic activity (2, 3, 7) . It has been recently demonstrated that eotaxin has a direct and selective profibrogenic effect on lung and bronchial fibroblasts, providing a novel mechanism whereby eotaxin 5 could participate in airway remodeling in asthma (7) .
Glucocorticoids are a first-line therapy to control airway inflammation and to improve both bronchial hyperresponsiveness and hyperreactivity in patients with asthma (2) .
There are however conflicting results; showing that in regard to fibroblast function, glucocorticoids may either reduce or increase fibroblast proliferation that may be related to airway remodeling (10) . It is unclear whether glucocorticoids either reduce or increase eotaxin production in lung fibroblasts, although they repressed the expression of eotaxin protein and mRNA induced by TNF-α and IL-4 in airway epithelial cells (11, 12) . In the present study, we investigate the regulation of eotaxin expression by dexamethasone and analyze its molecular mechanisms in human lung fibroblasts.
Cell Culture and Stimulation of the Cells
Normal Human Lung Fibroblasts (NHLF) (Clonetics, San Diego, CA) were cultured at 37 º C with 5% CO 2 in fibroblast cell basal medium (Clonetics) supplemented with fibroblast growth medium-2 (FGM-2 Single Quots, Clonetics); 1.0 µg/l human Fibroblast Growth Factor-Basic (rhFGF-B), 5.0 mg/l insulin, 2 % fetal bovine serum (FBS), 30 mg/ml gentamicin and 15 µg/ml amphotericin. NHLF cells were seeded into 12-well plates for enzyme-linked immunosorbent assay (ELISA) and luciferase assay, and 6 cm dishes for Western blot and mRNA analysis. Cells were allowed to grow to 70 % confluence. In one type of experiment, cells were exposed to IL-4 (40 ng/ml) (R&D Systems, Minneapolis, MN) or dexamethasone (DEX, 10 -6 to 10 -9
M)
(Sigma-Aldrich Co., St. Louis, MO) alone, or a combination of both. In other experiments, cells were treated with tumor necrosis factor (TNF)-α (40 ng/ml) (R&D Systems) and dexamethasone.
Assay of Eotaxin Protein Release into the Culture Medium
Concentrations of eotaxin in the collected culture medium were determined with a commercial system for ELISA (R&D Systems) in accord with the manufacturer's instructions. The limit of detection in the assay of eotaxin was 5 pg/ml.
Real-Time Quantitative PCR Analysis
Expressions of eotaxin, IL-4Rα, SOCS-1 and SOCS-3 mRNA in fibroblasts were determined by reverse transcription (RT), followed by real-time quantitative PCR. Total RNA was extracted from cells after incubation with or without indicated cytokines using Isogen reagent (Nippon Gene, Tokyo, Japan). Reverse transcription was performed using 1 µg of total RNA and oligo (dT) primers in a 20-µl reaction in accord with the manufacturer's protocol (Applied Biosystems, Branchburg, NJ). The sequences of the specific primer sets that were used in the real-time PCR analysis are displayed in Table 1 , as previously described (13, 14, 15) .
Real-time PCR was performed on an ABI Prism 7900HT sequence detection system (PE Applied Biosystems, Foster City, CA) using SYBR green (Applied Biosystems, Warrington, UK) as a dsDNA-specific binding dye. Reactions for eotaxin and β-actin were cycled 40 times after the initial denaturation of 95 º C, 10 min followed by 95 º C, 15
sec. The annealing and extension temperature was 60 º C, 1min, except for IL-4Rα, where it was 58 º C, 1 min. The threshold cycle (CT) was recorded for each sample to reflect mRNA expression levels. A validation experiment proved the linear dependence of the CT value for both eotaxin and β-actin concentrations and the consistency of ∆CT (eotaxin average CT minus β-actin average CT) in a given sample at different RNA concentrations. ∆CT was therefore used to reflect relative eotaxin mRNA expression levels. To determine the effects of different stimuli on eotaxin gene expression as compared with nonstimulated cells, ∆∆CT was calculated (∆∆CT=∆CT stimulus -∆CT nonstimulated cells). Eotaxin mRNA was indexed to β-actin using the formula 1/(2
∆∆CT was calculated to demonstrate the fold change of eotaxin gene expression in stimulated cells as compared with nonstimulated ones.
Expressions of IL-4Rα, SOCS-1 and SOCS-3 mRNA in fibroblasts were determined in the same manner to eotaxin mRNA expression. and then centrifuged to pellet cellular debris. The supernatants were measured for luciferase activity using a Dual-Luciferase Assay System (Promega Corporation). The firefly luciferase activity of the eotaxin promoter-reporter plasmid was normalized using Renilla luciferase activity.
Western Blot Analysis

Eotaxin and IL-4Rα mRNA Stability
NHLF cells were treated for 36 h with IL-4 (40 ng/ml) and dexamethasone (10 -6 M).
Cells were subsequently harvested at time 0 (as control) or further treated with actinomycin D (ACD, 1 µg/ml) (Sigma) for each specified time to block further transcription of mRNA. Eotaxin mRNA expression was analyzed 12 h, 24 h, and 36 h after ACD was added, and IL-4Rα mRNA expression at 2 h, 4 h, 8 h, and 12 h after ACD was added, as mentioned above.
Cloning of SOCS-1 expression vector and transfection into NHLF cells
A DNA fragment of the coding sequence of SOCS-1 was amplified by PCR using cDNA from IL-4-treated NHLF cells. The purified PCR product was digested with
BglII and EcoRI and cloned into the pAcGFP1-C1 vector (Clontech Laboratories Inc.
Shiga, Japan). The plasmid was analyzed by digestion with restriction enzymes and DNA sequencing. Plasmids for transfection were purified with HiSpeed Plasmid Maxi Kit (QIAGEN Sciences, Germantown, MD).
NHLF cells were seeded into six-well plates and allowed to grow to 50% confluence.
Cells were transfected with 4 µg of expression vector with 10 µl Lipofectamine 2000
(Promega) and grown in fibroblast cell basal medium containing FGM-2 Single Quots without antibiotics. After 24 h, the medium of the cells was changed to fibroblast cell basal medium with antibiotics; 30 mg/ml gentamicin and 15 µg/ml amphotericin. Then, cells were exposed to IL-4 (40 ng/ml) or dexamethasone (DEX, 10 -6 M) alone, or a combination of both. Forty-eight hours after coincubation, eotaxin or SOCS-1 mRNA expression was evaluated.
Knockdown of gene expression with short interfering RNA
Pre-designed short interfering RNA (siRNA) for SOCS-1 (catalogue number #45060) was purchased from Ambion (Tokyo, Japan). NHLF cells were seeded into six-well plates and allowed to grow to 50% confluence. Cells were transfected with 16.5 nM of siRNA with 5 µl Lipofectamine 2000. Then, the same procedures described for the knockdown of gene expression were performed. Scrambled siRNA was used as non-specific negative control of siRNA (Ambion).
Statistical Analysis
Data are expressed as means ± SD. Statistical differences were determined by ANOVA first before confirming significance with a paired Student's t test. Data were analyzed with Dr. SPSS II (SPSS Japan Inc., Tokyo, Japan). P values less than 0.05 were considered statistically significant.
Results
Eotaxin Protein Production and mRNA Expression
The minimum level of eotaxin protein was detected in the medium of unstimulated NHLF ( Figure 1A ). Coincubation with dexamethasone (DEX, 10 -6 M) alone until 48 h did not interfere with eotaxin production or mRNA expression in NHLF. 
Effect of Dexamethasone on IL-4Rα mRNA Expression
We next investigated IL-4Rα mRNA expression stimulated with IL-4 (40 ng/ml) and Figure 2C ).
Transient Transfection and Luciferase Assay
After 8 h, IL-4 alone enhanced induction of the eotaxin promoter, pEotx.1363 ( Figure   3A ). Coincubation with dexamethasone and IL-4 inhibited induction of the eotaxin promoter, and this effect was significant and concentration-dependent. By contrast, after 48 h, coincubation with dexamethasone and IL-4 significantly enhanced the activities of the eotaxin promoter, pEotx.1363, compared with either stimulus alone ( Figure 3B ).
Effect of Dexamethasone on IL-4-Induced SOCS-1 and SOCS-3 mRNA Expression
At all of the time points monitored, the expression of SOCS-1 mRNA was significantly Figure   4C ).
Effects of Dexamethasone on IL-4-Induced Eotaxin and IL-4Rα mRNA stability
There was no difference in the stabilities of eotaxin mRNA and IL-4Rα mRNA expressions between coincubation with IL-4 alone and combination with IL-4 and dexamethasone ( Figure 5A and 5B).
TNF-α-induced eotaxin and SOCS-1 mRNA
TNF-α (40 ng/ml) increased the expression of eotaxin mRNA at 24 h after stimulation, while the combination of TNF-α (40 ng/ml) and dexamethasone (DEX, 10 Such dual effects were also observed in other glucocorticoids, including hydrocortisone and prednisolone (data not shown).
Glucocorticoids suppress inflammatory genes by many different molecular mechanisms. production by IFN-γ may be due to up-regulation of IL-4Rα in airway epithelium (14) .
In the present study, we could not find mRNA expression of IL-4Rα enhanced by coincubation of IL-4 and dexamethasone. The effect of dexamethasone on STAT6 phosphorylation by IL-4 was examined by Western blotting for the latent and activated forms of the STAT6 protein at 36 h after coincubation with dexamethasone and IL-4.
IL-4 induced phosphorylation of STAT6 and p-STAT6 generation was enhanced by
dexamethasone in a concentration-dependent manner.
In the present study, eotaxin promoter activity was enhanced 48 h after coincubation with dexamethasone and IL-4, while it was inhibited at 8 h, suggesting that the transcription of eotaxin gene exhibits dual effects similar to the response of eotaxin production and mRNA expression. Dexamethasone alone induced an increase in eotaxin This suggested that eotaxin mRNA stability was unrelated; impling that posttranscriptional regulation such as eotaxin mRNA stability may be not involved in the enhanced expression of eotaxin by dexamethasone.
Finally, since Kraft et al. (10) found that IL-4 and dexamethasone significantly increased fibroblast proliferation in the biopsy specimens from subjects with mild asthma, we hypothesized that the numbers of NHLF coincubated with IL-4 and/or dexamethasone increased compared with the numbers of untreated cells. However, we did not find any differences in the numbers of viable cells with or without dexamethasone at 24 h to 72 h after coincubation (data not shown).
In conclusion, dexamethasone induced dual effects on the expression and production of eotaxin in lung fibroblasts. The mechanisms of the later enhanced production may depend on the prolonged transcriptional activity of the eotaxin gene, in part due to inhibition of SOCS-1 expression. Our findings showing a lesser antiinflammatory effect of glucocorticoids in fibroblasts may be relevant to the relatively insensitive to the effects of steroid therapy for difficult-to-treat asthma with increased progression of airway remodeling (21) . Because glucocorticoids are recommended as a first-line therapy for asthma, further study regarding the molecular mechanisms of glucocorticoids and cytokine modulation of fibroblast function is required to determine whether the currently available therapies for asthma provide long-term benefits for patients. Results are expressed as the relative quantity of eotaxin mRNA (= fold over control).
Data are presented as the mean ± SD of 4 to 6 independent experiments (* p< 0.05). Results are expressed as the relative quantity of SOCS-1 mRNA (= fold over control).
Data are presented as the mean ± SD of four independent experiments (**p< 0.01). 
